CCND1 and plasma cell neoplasm: Fifteen percent of patients with plasma cell neoplasms harbor t(11;14)(q13;q32) translocation, with consequent upregulation of cyclin D1, the cell cycle regulatory protein encoded by the CCND1 gene.